Axsome Therapeutics, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
AXSM on Nasdaq
Location
One World Trade Center, 22 Nd Floor, New York, NY

Insiders trading volume in the past year

Axsome Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Roger Jeffs Director $12M -$2.26M -15.8% Jun 7, 2024
Herriot Tabuteau CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner $3.6M Feb 27, 2024
Mark Coleman Director $2.68M -$789K -22.7% Nov 19, 2024
Mark Jacobson Chief Operating Officer $1.84M -$6.52M -78% Aug 9, 2024
Nick Pizzie Chief Financial Officer $1.19M Feb 27, 2024
R. Murdock General Counsel $974K Feb 27, 2024
Mark E. Saad Director $941K -$1.01M -51.7% Sep 11, 2024
Ari Maizel Chief Commercial Officer Oct 14, 2024
Susan Mahony Director Jun 7, 2024

Recent Insider Transactions by Companies or Individuals for Axsome Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.